Prime Capital Investment Advisors, LLC Apellis Pharmaceuticals, Inc. Transaction History

Prime Capital Investment Advisors, LLC

  • $6.88 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$55.39 - $72.47 $10,302 - $13,479
186 Added 4.87%
4,004 $235,000
Q4 2023

Jan 24, 2024
BUY
$37.14 - $64.82 $141,800 - $247,482
3,818 New
3,818 $228,000
Q2 2023

Aug 08, 2023
BUY
$76.68 - $93.31 $1.13 Million - $1.38 Million
14,800 Added 435.29%
18,200 $1.66 Million
Q1 2023

May 05, 2023
BUY
$46.59 - $66.96 $158,406 - $227,663
3,400 New
3,400 $224,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email